Net Income Increased 239% to $3.8 Million; Adjusted EBITDA Increased 205% to $5.8 Million on Record Revenue PLAINVIEW, NY / ACCESSWIRE / March 29, 2016 / Vasomedical, Inc. (“Vasomedical”) (OTC PK: VASO) today reported its operating results for the three months and year ended December 31, 2015. “With a 63% year-over-year growth in annual revenue...
Read More

Management to Hold Investor Conference Call on March 29, 2016 at 10:00 a.m. ET PLAINVIEW, NY / ACCESSWIRE / March 22, 2016 / Vasomedical, Inc. (PINKSHEETS: VASO) announced today that it will release its financial results for the three months and year ended December 31, 2015 on Tuesday, March 29, 2016, before market open. The...
Read More

PLAINVIEW, NY / ACCESSWIRE / January 6, 2016 / Vasomedical, Inc. (“Vasomedical”) (VASO) today announced the appointment of Shawl Lobree as President of Vaso Diagnostics, Inc. d/b/a/ VasoHealthcare, a wholly owned subsidiary of Vasomedical, effective January 1, 2016. VasoHealthcare has since July 1, 2010 been the exclusive representative for the sale of select GE Healthcare...
Read More

PLAINVIEW, NY / ACCESSWIRE / November 16, 2015 / Vasomedical, Inc. (“Vasomedical”) (OTC BB: VASO) today announced that it has been named on the Deloitte’s Technology Fast 500(TM) list for the fourth consecutive year. Deloitte’s Technology Fast 500 is a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies...
Read More

Reporting 128% Revenue Growth and Operating Profit of $1.3 Million for the Quarter PLAINVIEW, NY–(Marketwired – Nov 12, 2015) –  Vasomedical, Inc. (“Vasomedical”) (OTC PINK: VASO) today reported its operating results for the three months ended September 30, 2015. “We are very excited to report a 128% year-over-year revenue growth at Vasomedical for the third...
Read More